Hay fever treated with ACTH gel.

Area of Science:

• Allergy and Immunology
• Endocrinology
• Pharmacology

Background:

• Hay fever (allergic rhinitis) is a common condition affecting millions globally.
• Previous treatments for hay fever had varying efficacy and side effect profiles.
• Adrenocorticotropic hormone (ACTH) was explored for its potential anti-inflammatory properties in allergic conditions.

Purpose of the Study:

• To evaluate the efficacy and safety of ACTH gel as a treatment for seasonal allergic rhinitis (hay fever).
• To compare patient-reported outcomes and objective symptom reduction between ACTH gel and placebo groups.

Main Methods:

• A randomized controlled trial was conducted during the 1972-1974 hay fever seasons.
• Patients with hay fever received ACTH gel at different dosage schedules (80 units weekly or bi-weekly) or a placebo.
• Subjective patient satisfaction and objective symptom incidence were primary outcome measures.

Main Results:

• Patients treated with ACTH gel reported significantly higher satisfaction compared to the placebo group.
• Objective assessment showed a significantly lower incidence of hay fever symptoms in patients receiving ACTH gel.
• The treatment was generally well-tolerated, with few reported side effects.

Conclusions:

• ACTH gel demonstrated significant efficacy in reducing hay fever symptoms, both subjectively and objectively.
• The treatment was associated with a favorable safety profile, suggesting it as a viable option for hay fever management.
• Further research could explore optimal dosing and long-term effects of ACTH gel in allergic rhinitis.